合計 50 件の最近のインサイダー取引記録が記録されています Avenue Therapeutics, Inc. (ATXI), 内訳は 38 件の買い および 6 件の売り. インサイダー買い総額は $2.85M インサイダー売り総額は $3.06M.
最近活動のある主要インサイダーには Fortress Biotech, Inc., Herskowitz Neil, Kranzler Jay D. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — ATXI
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2025-03-31 |
Fortress Biotech, Inc. |
10 Percent Owner |
RSU 付与(制限付株式) |
33,724 |
- |
- |
328,524 |
| 2024-12-31 |
Fortress Biotech, Inc. |
10 Percent Owner |
不明 |
- |
- |
- |
294,800 |
| 2024-12-02 |
Herskowitz Neil |
Director |
情報に基づく売り |
23 |
$2.00 |
$46.00 |
97 |
| 2024-11-05 |
Kranzler Jay D |
Director |
情報に基づく売り |
61 |
$2.24 |
$136.64 |
559 |
| 2024-09-30 |
Kranzler Jay D |
Director |
情報に基づく買い |
497 |
$2.50 |
$1.24K |
620 |
| 2024-09-27 |
Kranzler Jay D |
Director |
情報に基づく買い |
3 |
$2.40 |
$7.20 |
123 |
| 2024-09-23 |
Rosenwald Lindsay A Md |
Director |
RSU 付与(制限付株式) |
30,000 |
$2.46 |
$73.8K |
30,000 |
| 2024-09-23 |
Kranzler Jay D |
Director |
RSU 付与(制限付株式) |
30,000 |
$2.46 |
$73.8K |
30,000 |
| 2024-09-23 |
Herskowitz Neil |
Director |
RSU 付与(制限付株式) |
30,000 |
$2.46 |
$73.8K |
30,000 |
| 2024-09-23 |
Oltmans Curtis Gale |
Director |
RSU 付与(制限付株式) |
30,000 |
$2.46 |
$73.8K |
30,000 |
| 2024-09-23 |
Charles Faith L. |
Director |
RSU 付与(制限付株式) |
30,000 |
$2.46 |
$73.8K |
30,000 |
| 2024-09-23 |
Jin David |
Interim Pfo and COO |
RSU 付与(制限付株式) |
65,000 |
- |
- |
65,000 |
| 2024-09-23 |
Maclean Alexandra |
Chief Executive Officer |
RSU 付与(制限付株式) |
170,000 |
- |
- |
170,000 |
| 2024-04-16 |
Fortress Biotech, Inc. |
10 Percent Owner |
RSU 付与(制限付株式) |
413,507 |
- |
- |
3,547,393 |
| 2024-01-02 |
Fortress Biotech, Inc. |
10 Percent Owner |
RSU 付与(制限付株式) |
2,101,496 |
- |
- |
3,133,886 |
| 2023-12-11 |
Davidow Robert L |
10 Percent Owner |
情報に基づく売り |
18,000 |
$0.15 |
$2.7K |
22,000 |
| 2023-10-31 |
Davidow Robert L |
10 Percent Owner |
不明 |
- |
- |
- |
40,000 |
| 2023-09-08 |
Rosenwald Lindsay A Md |
Director |
情報に基づく買い |
348,675 |
$0.72 |
$251.05K |
354,318 |
| 2023-09-08 |
Fortress Biotech, Inc. |
10 Percent Owner |
情報に基づく買い |
418,410 |
$0.72 |
$301.26K |
1,032,390 |
| 2023-06-30 |
Rosenwald Lindsay A Md |
Director |
RSU 付与(制限付株式) |
100,000 |
$1.14 |
$114K |
100,000 |
| 2023-06-30 |
Kranzler Jay D |
Director |
RSU 付与(制限付株式) |
100,000 |
$1.14 |
$114K |
100,000 |
| 2023-06-30 |
Herskowitz Neil |
Director |
RSU 付与(制限付株式) |
100,000 |
$1.14 |
$114K |
100,000 |
| 2023-06-30 |
Oltmans Curtis Gale |
Director |
RSU 付与(制限付株式) |
100,000 |
$1.14 |
$114K |
100,000 |
| 2023-06-30 |
Charles Faith L. |
Director |
RSU 付与(制限付株式) |
100,000 |
$1.14 |
$114K |
100,000 |
| 2023-06-30 |
Jin David |
Interim Pfo and COO |
RSU 付与(制限付株式) |
250,000 |
$1.14 |
$285K |
250,000 |
| 2023-06-29 |
Maclean Alexandra |
Chief Executive Officer |
RSU 付与(制限付株式) |
800,000 |
$1.14 |
$912K |
800,000 |
| 2023-03-31 |
Fortress Biotech, Inc. |
10 Percent Owner |
RSU 付与(制限付株式) |
52,419 |
- |
- |
613,980 |
| 2023-01-03 |
Fortress Biotech, Inc. |
Director |
RSU 付与(制限付株式) |
231,316 |
- |
- |
561,561 |
| 2022-12-31 |
Fortress Biotech, Inc. |
Director |
RSU 付与(制限付株式) |
90,909 |
- |
- |
330,245 |
| 2022-10-11 |
Invagen Pharmaceuticals, Inc. |
Director |
情報に基づく売り |
388,888 |
$7.71 |
$3M |
- |
| 2022-08-01 |
Maclean Alexandra |
Officer |
不明 |
- |
- |
- |
- |
| 2022-05-16 |
Charles Faith L. |
Director |
不明 |
- |
- |
- |
- |
| 2022-05-11 |
Jin David |
Officer |
不明 |
- |
- |
- |
- |
| 2021-12-17 |
Lu Lucy |
President, CEO |
RSU 付与(制限付株式) |
411,616 |
- |
- |
748,949 |
| 2021-12-17 |
Vazzano Joseph Walter |
Chief Financial Officer |
RSU 付与(制限付株式) |
100,505 |
- |
- |
165,757 |
| 2021-12-17 |
Kranzler Jay D |
Director |
RSU 付与(制限付株式) |
49,020 |
- |
- |
113,683 |
| 2021-12-17 |
Herskowitz Neil |
Director |
RSU 付与(制限付株式) |
49,020 |
- |
- |
163,744 |
| 2021-12-17 |
Oltmans Curtis Gale |
Director |
RSU 付与(制限付株式) |
49,020 |
- |
- |
49,020 |
| 2021-09-15 |
Vazzano Joseph Walter |
Chief Financial Officer |
情報に基づく売り |
7,160 |
$1.62 |
$11.6K |
65,252 |
| 2021-05-06 |
Herskowitz Neil |
Director |
情報に基づく買い |
2,500 |
$3.99 |
$9.98K |
134,724 |
| 2021-04-01 |
Oltmans Curtis Gale |
Director |
不明 |
- |
- |
- |
- |
| 2020-08-20 |
Vazzano Joseph Walter |
Chief Financial Officer |
情報に基づく売り |
3,840 |
$12.13 |
$46.58K |
57,412 |
| 2020-06-16 |
Kranzler Jay D |
Director |
RSU 付与(制限付株式) |
10,000 |
- |
- |
84,663 |
| 2020-06-16 |
Herskowitz Neil |
Director |
RSU 付与(制限付株式) |
10,000 |
- |
- |
132,224 |
| 2020-03-10 |
Vazzano Joseph Walter |
Chief Financial Officer |
情報に基づく買い |
1,889 |
$7.94 |
$15K |
61,252 |
| 2020-03-09 |
Vazzano Joseph Walter |
Chief Financial Officer |
情報に基づく買い |
1,400 |
$7.99 |
$11.19K |
59,263 |
| 2020-02-27 |
Herskowitz Neil |
Director |
情報に基づく買い |
2,400 |
$8.20 |
$19.68K |
122,224 |
| 2020-02-26 |
Herskowitz Neil |
Director |
情報に基づく買い |
161 |
$8.73 |
$1.41K |
119,824 |
| 2020-02-25 |
Herskowitz Neil |
Director |
情報に基づく買い |
10,000 |
$9.31 |
$93.1K |
119,663 |
| 2020-02-25 |
Vazzano Joseph Walter |
Chief Financial Officer |
情報に基づく買い |
1,200 |
$9.09 |
$10.91K |
57,863 |
■ 情報付き — 公開市場取引(最も重要)
■ 情報なし(買い) — 報酬・オプション行使・転換
■ 情報なし(売り) — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効